Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.15) by 26.67 percent. This is a 8.33 percent increase over losses of $(0.12) per share from the same period last year.
AudioEye: Q2 Earnings Insights
Shares of AudioEye (NASDAQ:AEYE) fell 25.1% in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share increased 18.75% year over year to ($0.13), which beat the estimate of ($0.29).